Back

Diagnosing arrhythmogenic ventricular cardiomyopathy: a re-appraisal of the role and normal range of the signal-averaged ECG

25 April 2021 (08:00 - 09:00)
Organised by:
Congress Presentation Part of: New diagnostic methods in EP II Signal-Averaged Electrocardiography EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Mohammed Obeidat

University of Manchester, Manchester (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Non-algorithmic approach to accessory pathway localization based on a mobile app
Professor M. Jastrzebski (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
Buccal mucosa cells as a diagnostic tool in patients with arrhythmogenic cardiomyopathy
Ms S. Van Der Voorn (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Anatomical localization and classification of bundle branch blocks using novel CineECG.
Miss M. Boonstra (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Diagnostic value of ECG characteristics in precordial leads V1-V3 for the diagnosis of the origin of outflow tract ventricular arrhythmias with a lead V3 precordial transition.
Doctor L. Lazzari (Terni, IT)
Abstract Slides Video
Presentation thumbnail
QT interval estimation in patients with right bundle branch block using validated formulas for left bundle branch block
Doctor S. Garcia Gomez (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
New diagnostic methods in EP II

The Event

Event poster

EHRA 2021

25 April 2021 08:00 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources